id	sid	tid	token	lemma	pos
dpc-5848	1	1	dermatology	dermatology	NOUN
dpc-5848	1	2	:	:	PUNCT
dpc-5848	1	3	practical	practical	ADJ
dpc-5848	1	4	and	and	CCONJ
dpc-5848	1	5	conceptual	conceptual	ADJ
dpc-5848	1	6	research	research	NOUN
dpc-5848	1	7	letter	letter	NOUN
dpc-5848	2	1	|	|	ADV
dpc-5848	2	2	dermatol	dermatol	ADJ
dpc-5848	2	3	pract	pract	NOUN
dpc-5848	2	4	concept	concept	NOUN
dpc-5848	2	5	.	.	PUNCT
dpc-5848	3	1	2025;15(4):5848	2025;15(4):5848	NUM
dpc-5848	3	2	1	1	NUM
dpc-5848	3	3	oral	oral	ADJ
dpc-5848	3	4	erosive	erosive	NOUN
dpc-5848	3	5	lichen	lichen	NOUN
dpc-5848	3	6	planus	planus	PROPN
dpc-5848	3	7	successfully	successfully	ADV
dpc-5848	3	8	treated	treat	VERB
dpc-5848	3	9	with	with	ADP
dpc-5848	3	10	baricitinib	baricitinib	NOUN
dpc-5848	3	11	samuele	samuele	PROPN
dpc-5848	3	12	savian1	savian1	PROPN
dpc-5848	3	13	,	,	PUNCT
dpc-5848	3	14	roberto	roberto	PROPN
dpc-5848	3	15	maglie1	maglie1	PROPN
dpc-5848	3	16	,	,	PUNCT
dpc-5848	3	17	maria	maria	PROPN
dpc-5848	3	18	efenesia	efenesia	PROPN
dpc-5848	3	19	baffa1	baffa1	PROPN
dpc-5848	3	20	,	,	PUNCT
dpc-5848	3	21	carlo	carlo	NOUN
dpc-5848	3	22	pipitò1	pipitò1	PROPN
dpc-5848	3	23	,	,	PUNCT
dpc-5848	3	24	vincenzina	vincenzina	PROPN
dpc-5848	3	25	rubino1	rubino1	PROPN
dpc-5848	3	26	,	,	PUNCT
dpc-5848	3	27	stefano	stefano	PROPN
dpc-5848	3	28	senatore1	senatore1	PROPN
dpc-5848	3	29	,	,	PUNCT
dpc-5848	3	30	emiliano	emiliano	PROPN
dpc-5848	3	31	antiga1	antiga1	PROPN
dpc-5848	3	32	1	1	NUM
dpc-5848	3	33	section	section	NOUN
dpc-5848	3	34	of	of	ADP
dpc-5848	3	35	dermatology	dermatology	NOUN
dpc-5848	3	36	,	,	PUNCT
dpc-5848	3	37	department	department	NOUN
dpc-5848	3	38	of	of	ADP
dpc-5848	3	39	health	health	PROPN
dpc-5848	3	40	sciences	sciences	PROPN
dpc-5848	3	41	,	,	PUNCT
dpc-5848	3	42	university	university	NOUN
dpc-5848	3	43	of	of	ADP
dpc-5848	3	44	florence	florence	NOUN
dpc-5848	3	45	,	,	PUNCT
dpc-5848	3	46	florence	florence	NOUN
dpc-5848	3	47	,	,	PUNCT
dpc-5848	3	48	italy	italy	PROPN
dpc-5848	3	49	citation	citation	NOUN
dpc-5848	3	50	:	:	PUNCT
dpc-5848	3	51	savian	savian	PROPN
dpc-5848	3	52	s	s	PART
dpc-5848	3	53	,	,	PUNCT
dpc-5848	3	54	maglie	maglie	PROPN
dpc-5848	3	55	r	r	PROPN
dpc-5848	3	56	,	,	PUNCT
dpc-5848	3	57	baffa	baffa	NOUN
dpc-5848	3	58	me	i	PRON
dpc-5848	3	59	,	,	PUNCT
dpc-5848	3	60	pipitò	pipitò	PROPN
dpc-5848	3	61	c	c	NOUN
dpc-5848	3	62	,	,	PUNCT
dpc-5848	3	63	rubino	rubino	NOUN
dpc-5848	3	64	v	v	NOUN
dpc-5848	3	65	,	,	PUNCT
dpc-5848	3	66	senatore	senatore	NOUN
dpc-5848	3	67	s	s	PROPN
dpc-5848	3	68	,	,	PUNCT
dpc-5848	3	69	antiga	antiga	PROPN
dpc-5848	3	70	e.	e.	PROPN
dpc-5848	3	71	oral	oral	PROPN
dpc-5848	3	72	erosive	erosive	PROPN
dpc-5848	3	73	lichen	lichen	NOUN
dpc-5848	3	74	planus	planus	PROPN
dpc-5848	3	75	successfully	successfully	ADV
dpc-5848	3	76	treated	treat	VERB
dpc-5848	3	77	with	with	ADP
dpc-5848	3	78	baricitinib	baricitinib	NOUN
dpc-5848	3	79	.	.	PUNCT
dpc-5848	4	1	dermatol	dermatol	NOUN
dpc-5848	4	2	pract	pract	PROPN
dpc-5848	4	3	concept	concept	NOUN
dpc-5848	4	4	.	.	PUNCT
dpc-5848	5	1	2025;15(4):5848	2025;15(4):5848	NUM
dpc-5848	5	2	.	.	PUNCT
dpc-5848	6	1	doi	doi	PROPN
dpc-5848	6	2	:	:	PUNCT
dpc-5848	6	3	https://doi.org/10.5826/dpc.1504a5848	https://doi.org/10.5826/dpc.1504a5848	NOUN
dpc-5848	6	4	accepted	accept	VERB
dpc-5848	6	5	:	:	PUNCT
dpc-5848	6	6	april	april	PROPN
dpc-5848	6	7	9	9	NUM
dpc-5848	6	8	,	,	PUNCT
dpc-5848	6	9	2025	2025	NUM
dpc-5848	6	10	;	;	PUNCT
dpc-5848	6	11	published	publish	VERB
dpc-5848	6	12	:	:	PUNCT
dpc-5848	7	1	october	october	PROPN
dpc-5848	7	2	2025	2025	NUM
dpc-5848	7	3	copyright	copyright	NOUN
dpc-5848	7	4	:	:	PUNCT
dpc-5848	7	5	©	©	PROPN
dpc-5848	7	6	2025	2025	NUM
dpc-5848	7	7	savian	savian	NOUN
dpc-5848	7	8	et	et	PROPN
dpc-5848	7	9	al	al	PROPN
dpc-5848	7	10	.	.	PUNCT
dpc-5848	8	1	this	this	PRON
dpc-5848	8	2	is	be	AUX
dpc-5848	8	3	an	an	DET
dpc-5848	8	4	open	open	ADJ
dpc-5848	8	5	-	-	PUNCT
dpc-5848	8	6	access	access	NOUN
dpc-5848	8	7	article	article	NOUN
dpc-5848	8	8	distributed	distribute	VERB
dpc-5848	8	9	under	under	ADP
dpc-5848	8	10	the	the	DET
dpc-5848	8	11	terms	term	NOUN
dpc-5848	8	12	of	of	ADP
dpc-5848	8	13	the	the	DET
dpc-5848	8	14	creative	creative	ADJ
dpc-5848	8	15	commons	common	NOUN
dpc-5848	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5848	8	17	license	license	NOUN
dpc-5848	8	18	(	(	PUNCT
dpc-5848	8	19	by	by	ADP
dpc-5848	8	20	-	-	PUNCT
dpc-5848	8	21	nc-4.0	nc-4.0	NOUN
dpc-5848	8	22	)	)	PUNCT
dpc-5848	8	23	,	,	PUNCT
dpc-5848	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5848	8	25	,	,	PUNCT
dpc-5848	8	26	which	which	PRON
dpc-5848	8	27	permits	permit	VERB
dpc-5848	8	28	unrestricted	unrestricted	ADJ
dpc-5848	8	29	noncommercial	noncommercial	ADJ
dpc-5848	8	30	use	use	NOUN
dpc-5848	8	31	,	,	PUNCT
dpc-5848	8	32	distribution	distribution	NOUN
dpc-5848	8	33	,	,	PUNCT
dpc-5848	8	34	and	and	CCONJ
dpc-5848	8	35	reproduction	reproduction	NOUN
dpc-5848	8	36	in	in	ADP
dpc-5848	8	37	any	any	DET
dpc-5848	8	38	medium	medium	NOUN
dpc-5848	8	39	,	,	PUNCT
dpc-5848	8	40	provided	provide	VERB
dpc-5848	8	41	the	the	DET
dpc-5848	8	42	original	original	ADJ
dpc-5848	8	43	authors	author	NOUN
dpc-5848	8	44	and	and	CCONJ
dpc-5848	8	45	source	source	NOUN
dpc-5848	8	46	are	be	AUX
dpc-5848	8	47	credited	credit	VERB
dpc-5848	8	48	.	.	PUNCT
dpc-5848	9	1	funding	funding	NOUN
dpc-5848	9	2	:	:	PUNCT
dpc-5848	9	3	none	none	NOUN
dpc-5848	9	4	.	.	PUNCT
dpc-5848	10	1	competing	compete	VERB
dpc-5848	10	2	interests	interest	NOUN
dpc-5848	10	3	:	:	PUNCT
dpc-5848	10	4	none	none	NOUN
dpc-5848	10	5	.	.	PUNCT
dpc-5848	11	1	authorship	authorship	NOUN
dpc-5848	11	2	:	:	PUNCT
dpc-5848	11	3	all	all	DET
dpc-5848	11	4	authors	author	NOUN
dpc-5848	11	5	have	have	AUX
dpc-5848	11	6	contributed	contribute	VERB
dpc-5848	11	7	significantly	significantly	ADV
dpc-5848	11	8	to	to	ADP
dpc-5848	11	9	this	this	DET
dpc-5848	11	10	publication	publication	NOUN
dpc-5848	11	11	.	.	PUNCT
dpc-5848	12	1	corresponding	correspond	VERB
dpc-5848	12	2	author	author	NOUN
dpc-5848	12	3	:	:	PUNCT
dpc-5848	12	4	samuele	samuele	PROPN
dpc-5848	12	5	savian	savian	PROPN
dpc-5848	12	6	,	,	PUNCT
dpc-5848	12	7	md	md	PROPN
dpc-5848	12	8	,	,	PUNCT
dpc-5848	12	9	department	department	PROPN
dpc-5848	12	10	of	of	ADP
dpc-5848	12	11	health	health	PROPN
dpc-5848	12	12	sciences	sciences	PROPN
dpc-5848	12	13	,	,	PUNCT
dpc-5848	12	14	section	section	NOUN
dpc-5848	12	15	of	of	ADP
dpc-5848	12	16	dermatology	dermatology	NOUN
dpc-5848	12	17	,	,	PUNCT
dpc-5848	12	18	university	university	NOUN
dpc-5848	12	19	of	of	ADP
dpc-5848	12	20	florence	florence	NOUN
dpc-5848	12	21	viale	viale	PROPN
dpc-5848	12	22	michelangelo	michelangelo	NOUN
dpc-5848	12	23	41	41	NUM
dpc-5848	12	24	,	,	PUNCT
dpc-5848	12	25	florence	florence	NOUN
dpc-5848	12	26	,	,	PUNCT
dpc-5848	12	27	italy	italy	PROPN
dpc-5848	12	28	,	,	PUNCT
dpc-5848	12	29	50125	50125	NUM
dpc-5848	12	30	.	.	PUNCT
dpc-5848	13	1	email	email	NOUN
dpc-5848	13	2	:	:	PUNCT
dpc-5848	13	3	samuele.savian@unifi.it	samuele.savian@unifi.it	NOUN
dpc-5848	13	4	introduction	introduction	NOUN
dpc-5848	13	5	lichen	lichen	NOUN
dpc-5848	13	6	planus	planus	NOUN
dpc-5848	13	7	(	(	PUNCT
dpc-5848	13	8	lp	lp	NOUN
dpc-5848	13	9	)	)	PUNCT
dpc-5848	13	10	is	be	AUX
dpc-5848	13	11	a	a	DET
dpc-5848	13	12	chronic	chronic	ADJ
dpc-5848	13	13	inflammatory	inflammatory	ADJ
dpc-5848	13	14	disorder	disorder	NOUN
dpc-5848	13	15	that	that	PRON
dpc-5848	13	16	most	most	ADV
dpc-5848	13	17	often	often	ADV
dpc-5848	13	18	affects	affect	VERB
dpc-5848	13	19	middle	middle	ADJ
dpc-5848	13	20	-	-	PUNCT
dpc-5848	13	21	aged	aged	ADJ
dpc-5848	13	22	adults	adult	NOUN
dpc-5848	13	23	.	.	PUNCT
dpc-5848	14	1	lp	lp	PROPN
dpc-5848	14	2	can	can	AUX
dpc-5848	14	3	involve	involve	VERB
dpc-5848	14	4	the	the	DET
dpc-5848	14	5	skin	skin	NOUN
dpc-5848	14	6	or	or	CCONJ
dpc-5848	14	7	mucous	mucous	ADJ
dpc-5848	14	8	membranes	membrane	NOUN
dpc-5848	14	9	including	include	VERB
dpc-5848	14	10	the	the	DET
dpc-5848	14	11	oral	oral	ADJ
dpc-5848	14	12	,	,	PUNCT
dpc-5848	14	13	vulvovaginal	vulvovaginal	ADJ
dpc-5848	14	14	,	,	PUNCT
dpc-5848	14	15	esophageal	esophageal	ADJ
dpc-5848	14	16	,	,	PUNCT
dpc-5848	14	17	laryngeal	laryngeal	ADJ
dpc-5848	14	18	,	,	PUNCT
dpc-5848	14	19	and	and	CCONJ
dpc-5848	14	20	conjunctival	conjunctival	ADJ
dpc-5848	14	21	mucosa	mucosa	NOUN
dpc-5848	14	22	.	.	PUNCT
dpc-5848	15	1	it	it	PRON
dpc-5848	15	2	has	have	VERB
dpc-5848	15	3	different	different	ADJ
dpc-5848	15	4	variants	variant	NOUN
dpc-5848	15	5	based	base	VERB
dpc-5848	15	6	on	on	ADP
dpc-5848	15	7	the	the	DET
dpc-5848	15	8	morphology	morphology	NOUN
dpc-5848	15	9	of	of	ADP
dpc-5848	15	10	the	the	DET
dpc-5848	15	11	lesions	lesion	NOUN
dpc-5848	15	12	and	and	CCONJ
dpc-5848	15	13	the	the	DET
dpc-5848	15	14	site	site	NOUN
dpc-5848	15	15	of	of	ADP
dpc-5848	15	16	involvement.[1	involvement.[1	ADJ
dpc-5848	15	17	]	]	SYM
dpc-5848	15	18	 	 	SPACE
dpc-5848	15	19	oral	oral	ADJ
dpc-5848	15	20	lichen	lichen	NOUN
dpc-5848	15	21	planus	planus	NOUN
dpc-5848	15	22	(	(	PUNCT
dpc-5848	15	23	olp	olp	PROPN
dpc-5848	15	24	)	)	PUNCT
dpc-5848	15	25	is	be	AUX
dpc-5848	15	26	one	one	NUM
dpc-5848	15	27	of	of	ADP
dpc-5848	15	28	the	the	DET
dpc-5848	15	29	most	most	ADV
dpc-5848	15	30	common	common	ADJ
dpc-5848	15	31	variants	variant	NOUN
dpc-5848	15	32	of	of	ADP
dpc-5848	15	33	lp	lp	NOUN
dpc-5848	15	34	,	,	PUNCT
dpc-5848	15	35	showing	show	VERB
dpc-5848	15	36	different	different	ADJ
dpc-5848	15	37	clinical	clinical	ADJ
dpc-5848	15	38	presentations	presentation	NOUN
dpc-5848	15	39	;	;	PUNCT
dpc-5848	15	40	among	among	ADP
dpc-5848	15	41	them	they	PRON
dpc-5848	15	42	,	,	PUNCT
dpc-5848	15	43	erosive	erosive	VERB
dpc-5848	15	44	olp	olp	PROPN
dpc-5848	15	45	severely	severely	ADV
dpc-5848	15	46	affects	affect	VERB
dpc-5848	15	47	the	the	DET
dpc-5848	15	48	quality	quality	NOUN
dpc-5848	15	49	of	of	ADP
dpc-5848	15	50	life	life	NOUN
dpc-5848	15	51	of	of	ADP
dpc-5848	15	52	the	the	DET
dpc-5848	15	53	patients	patient	NOUN
dpc-5848	15	54	,	,	PUNCT
dpc-5848	15	55	resulting	result	VERB
dpc-5848	15	56	in	in	ADP
dpc-5848	15	57	painful	painful	ADJ
dpc-5848	15	58	erosion	erosion	NOUN
dpc-5848	15	59	of	of	ADP
dpc-5848	15	60	the	the	DET
dpc-5848	15	61	mucous	mucous	ADJ
dpc-5848	15	62	membranes	membrane	NOUN
dpc-5848	15	63	.	.	PUNCT
dpc-5848	16	1	management	management	NOUN
dpc-5848	16	2	of	of	ADP
dpc-5848	16	3	erosive	erosive	ADJ
dpc-5848	16	4	olp	olp	PROPN
dpc-5848	16	5	has	have	AUX
dpc-5848	16	6	proven	prove	VERB
dpc-5848	16	7	to	to	PART
dpc-5848	16	8	be	be	AUX
dpc-5848	16	9	difficult	difficult	ADJ
dpc-5848	16	10	;	;	PUNCT
dpc-5848	16	11	however	however	ADV
dpc-5848	16	12	,	,	PUNCT
dpc-5848	16	13	recent	recent	ADJ
dpc-5848	16	14	reports	report	NOUN
dpc-5848	16	15	of	of	ADP
dpc-5848	16	16	treatment	treatment	NOUN
dpc-5848	16	17	with	with	ADP
dpc-5848	16	18	janus	janus	PROPN
dpc-5848	16	19	kinase	kinase	PROPN
dpc-5848	16	20	inhibitors	inhibitor	NOUN
dpc-5848	16	21	(	(	PUNCT
dpc-5848	16	22	jaki	jaki	PROPN
dpc-5848	16	23	)	)	PUNCT
dpc-5848	16	24	such	such	ADJ
dpc-5848	16	25	as	as	ADP
dpc-5848	16	26	baricitinib	baricitinib	NOUN
dpc-5848	16	27	are	be	AUX
dpc-5848	16	28	encouraging	encouraging	ADJ
dpc-5848	16	29	.	.	PUNCT
dpc-5848	17	1	[	[	X
dpc-5848	17	2	2	2	X
dpc-5848	17	3	]	]	PUNCT
dpc-5848	17	4	this	this	DET
dpc-5848	17	5	paper	paper	NOUN
dpc-5848	17	6	reports	report	VERB
dpc-5848	17	7	the	the	DET
dpc-5848	17	8	successful	successful	ADJ
dpc-5848	17	9	treatment	treatment	NOUN
dpc-5848	17	10	of	of	ADP
dpc-5848	17	11	erosive	erosive	ADJ
dpc-5848	17	12	olp	olp	PROPN
dpc-5848	17	13	with	with	ADP
dpc-5848	17	14	baricitinib	baricitinib	NOUN
dpc-5848	17	15	in	in	ADP
dpc-5848	17	16	a	a	DET
dpc-5848	17	17	patient	patient	NOUN
dpc-5848	17	18	with	with	ADP
dpc-5848	17	19	recalcitrant	recalcitrant	ADJ
dpc-5848	17	20	disease	disease	NOUN
dpc-5848	17	21	.	.	PUNCT
dpc-5848	18	1	case	case	NOUN
dpc-5848	18	2	presentation	presentation	NOUN
dpc-5848	18	3	a	a	DET
dpc-5848	18	4	79	79	NUM
dpc-5848	18	5	-	-	PUNCT
dpc-5848	18	6	year	year	NOUN
dpc-5848	18	7	-	-	PUNCT
dpc-5848	18	8	old	old	ADJ
dpc-5848	18	9	female	female	NOUN
dpc-5848	18	10	presented	present	VERB
dpc-5848	18	11	painful	painful	ADJ
dpc-5848	18	12	erosions	erosion	NOUN
dpc-5848	18	13	and	and	CCONJ
dpc-5848	18	14	ulcerations	ulceration	NOUN
dpc-5848	18	15	of	of	ADP
dpc-5848	18	16	the	the	DET
dpc-5848	18	17	ventrolateral	ventrolateral	ADJ
dpc-5848	18	18	region	region	NOUN
dpc-5848	18	19	of	of	ADP
dpc-5848	18	20	the	the	DET
dpc-5848	18	21	tongue	tongue	NOUN
dpc-5848	18	22	with	with	ADP
dpc-5848	18	23	oral	oral	ADJ
dpc-5848	18	24	disease	disease	NOUN
dpc-5848	18	25	severity	severity	NOUN
dpc-5848	18	26	score	score	NOUN
dpc-5848	18	27	(	(	PUNCT
dpc-5848	18	28	odss	odss	NOUN
dpc-5848	18	29	)	)	PUNCT
dpc-5848	18	30	=	=	NOUN
dpc-5848	18	31	12	12	NUM
dpc-5848	18	32	(	(	PUNCT
dpc-5848	18	33	figure	figure	NOUN
dpc-5848	18	34	1a	1a	NOUN
dpc-5848	18	35	)	)	PUNCT
dpc-5848	18	36	and	and	CCONJ
dpc-5848	18	37	lesions	lesion	NOUN
dpc-5848	18	38	compatible	compatible	ADJ
dpc-5848	18	39	with	with	ADP
dpc-5848	18	40	lp	lp	NOUN
dpc-5848	18	41	on	on	ADP
dpc-5848	18	42	the	the	DET
dpc-5848	18	43	back	back	NOUN
dpc-5848	18	44	of	of	ADP
dpc-5848	18	45	the	the	DET
dpc-5848	18	46	hands	hand	NOUN
dpc-5848	18	47	,	,	PUNCT
dpc-5848	18	48	on	on	ADP
dpc-5848	18	49	the	the	DET
dpc-5848	18	50	volar	volar	ADJ
dpc-5848	18	51	surface	surface	NOUN
dpc-5848	18	52	of	of	ADP
dpc-5848	18	53	forearms	forearm	NOUN
dpc-5848	18	54	,	,	PUNCT
dpc-5848	18	55	and	and	CCONJ
dpc-5848	18	56	on	on	ADP
dpc-5848	18	57	the	the	DET
dpc-5848	18	58	soles	sol	NOUN
dpc-5848	18	59	,	,	PUNCT
dpc-5848	18	60	with	with	ADP
dpc-5848	18	61	papules	papule	NOUN
dpc-5848	18	62	showing	show	VERB
dpc-5848	18	63	clinical	clinical	ADJ
dpc-5848	18	64	features	feature	NOUN
dpc-5848	18	65	of	of	ADP
dpc-5848	18	66	hypertrophic	hypertrophic	ADJ
dpc-5848	18	67	lp	lp	NOUN
dpc-5848	18	68	.	.	PUNCT
dpc-5848	19	1	after	after	ADP
dpc-5848	19	2	confirmation	confirmation	NOUN
dpc-5848	19	3	of	of	ADP
dpc-5848	19	4	the	the	DET
dpc-5848	19	5	diagnosis	diagnosis	NOUN
dpc-5848	19	6	,	,	PUNCT
dpc-5848	19	7	treatment	treatment	NOUN
dpc-5848	19	8	with	with	ADP
dpc-5848	19	9	prednisone	prednisone	PROPN
dpc-5848	19	10	50	50	NUM
dpc-5848	19	11	mg	mg	NOUN
dpc-5848	19	12	and	and	CCONJ
dpc-5848	19	13	methotrexate	methotrexate	VERB
dpc-5848	19	14	12.5	12.5	NUM
dpc-5848	19	15	mg	mg	NOUN
dpc-5848	19	16	/	/	SYM
dpc-5848	19	17	day	day	NOUN
dpc-5848	19	18	was	be	AUX
dpc-5848	19	19	started	start	VERB
dpc-5848	19	20	,	,	PUNCT
dpc-5848	19	21	with	with	ADP
dpc-5848	19	22	marked	mark	VERB
dpc-5848	19	23	improvement	improvement	NOUN
dpc-5848	19	24	of	of	ADP
dpc-5848	19	25	the	the	DET
dpc-5848	19	26	skin	skin	NOUN
dpc-5848	19	27	manifestations	manifestation	NOUN
dpc-5848	19	28	after	after	ADP
dpc-5848	19	29	12	12	NUM
dpc-5848	19	30	weeks	week	NOUN
dpc-5848	19	31	of	of	ADP
dpc-5848	19	32	treatment	treatment	NOUN
dpc-5848	19	33	.	.	PUNCT
dpc-5848	20	1	in	in	ADP
dpc-5848	20	2	contrast	contrast	NOUN
dpc-5848	20	3	,	,	PUNCT
dpc-5848	20	4	the	the	DET
dpc-5848	20	5	involvement	involvement	NOUN
dpc-5848	20	6	of	of	ADP
dpc-5848	20	7	the	the	DET
dpc-5848	20	8	oral	oral	ADJ
dpc-5848	20	9	cavity	cavity	NOUN
dpc-5848	20	10	did	do	AUX
dpc-5848	20	11	not	not	PART
dpc-5848	20	12	show	show	VERB
dpc-5848	20	13	significant	significant	ADJ
dpc-5848	20	14	improvement	improvement	NOUN
dpc-5848	20	15	despite	despite	SCONJ
dpc-5848	20	16	the	the	DET
dpc-5848	20	17	multiple	multiple	ADJ
dpc-5848	20	18	treatments	treatment	NOUN
dpc-5848	20	19	,	,	PUNCT
dpc-5848	20	20	including	include	VERB
dpc-5848	20	21	prednisone	prednisone	NOUN
dpc-5848	20	22	,	,	PUNCT
dpc-5848	20	23	methotrexate	methotrexate	NOUN
dpc-5848	20	24	,	,	PUNCT
dpc-5848	20	25	azathioprine	azathioprine	NOUN
dpc-5848	20	26	,	,	PUNCT
dpc-5848	20	27	topical	topical	ADJ
dpc-5848	20	28	clobetasol	clobetasol	NOUN
dpc-5848	20	29	propionate	propionate	NOUN
dpc-5848	20	30	0.05	0.05	NUM
dpc-5848	20	31	%	%	NOUN
dpc-5848	20	32	,	,	PUNCT
dpc-5848	20	33	and	and	CCONJ
dpc-5848	20	34	intralesional	intralesional	ADJ
dpc-5848	20	35	triamcinolone	triamcinolone	NOUN
dpc-5848	20	36	.	.	PUNCT
dpc-5848	21	1	considering	consider	VERB
dpc-5848	21	2	the	the	DET
dpc-5848	21	3	patient	patient	NOUN
dpc-5848	21	4	’s	’s	PART
dpc-5848	21	5	poor	poor	ADJ
dpc-5848	21	6	clinical	clinical	ADJ
dpc-5848	21	7	control	control	NOUN
dpc-5848	21	8	and	and	CCONJ
dpc-5848	21	9	reduced	reduce	VERB
dpc-5848	21	10	quality	quality	NOUN
dpc-5848	21	11	of	of	ADP
dpc-5848	21	12	life	life	NOUN
dpc-5848	21	13	due	due	ADP
dpc-5848	21	14	to	to	ADP
dpc-5848	21	15	the	the	DET
dpc-5848	21	16	persistence	persistence	NOUN
dpc-5848	21	17	of	of	ADP
dpc-5848	21	18	erosive	erosive	ADJ
dpc-5848	21	19	mucosal	mucosal	NOUN
dpc-5848	21	20	lesions	lesion	NOUN
dpc-5848	21	21	,	,	PUNCT
dpc-5848	21	22	off	off	ADP
dpc-5848	21	23	-	-	PUNCT
dpc-5848	21	24	label	label	NOUN
dpc-5848	21	25	therapy	therapy	NOUN
dpc-5848	21	26	with	with	ADP
dpc-5848	21	27	baricitinib	baricitinib	NOUN
dpc-5848	21	28	4	4	NUM
dpc-5848	21	29	mg	mg	NUM
dpc-5848	21	30	/	/	SYM
dpc-5848	21	31	day	day	NOUN
dpc-5848	21	32	was	be	AUX
dpc-5848	21	33	introduced	introduce	VERB
dpc-5848	21	34	,	,	PUNCT
dpc-5848	21	35	while	while	SCONJ
dpc-5848	21	36	maintaining	maintain	VERB
dpc-5848	21	37	prednisone	prednisone	NOUN
dpc-5848	21	38	5	5	NUM
dpc-5848	21	39	mg	mg	PROPN
dpc-5848	21	40	/	/	SYM
dpc-5848	21	41	day	day	NOUN
dpc-5848	21	42	.	.	PUNCT
dpc-5848	22	1	after	after	ADP
dpc-5848	22	2	three	three	NUM
dpc-5848	22	3	months	month	NOUN
dpc-5848	22	4	of	of	ADP
dpc-5848	22	5	baricitinib	baricitinib	NOUN
dpc-5848	22	6	treatment	treatment	NOUN
dpc-5848	22	7	,	,	PUNCT
dpc-5848	22	8	there	there	PRON
dpc-5848	22	9	was	be	VERB
dpc-5848	22	10	a	a	DET
dpc-5848	22	11	marked	mark	VERB
dpc-5848	22	12	improvement	improvement	NOUN
dpc-5848	22	13	,	,	PUNCT
dpc-5848	22	14	with	with	ADP
dpc-5848	22	15	odss=4	odss=4	PROPN
dpc-5848	22	16	,	,	PUNCT
dpc-5848	22	17	followed	follow	VERB
dpc-5848	22	18	by	by	ADP
dpc-5848	22	19	a	a	DET
dpc-5848	22	20	complete	complete	ADJ
dpc-5848	22	21	remission	remission	NOUN
dpc-5848	22	22	after	after	ADP
dpc-5848	22	23	five	five	NUM
dpc-5848	22	24	months	month	NOUN
dpc-5848	22	25	(	(	PUNCT
dpc-5848	22	26	odss=0	odss=0	NUM
dpc-5848	22	27	)	)	PUNCT
dpc-5848	22	28	(	(	PUNCT
dpc-5848	22	29	figure	figure	NOUN
dpc-5848	22	30	1b	1b	NUM
dpc-5848	22	31	)	)	PUNCT
dpc-5848	22	32	,	,	PUNCT
dpc-5848	22	33	which	which	PRON
dpc-5848	22	34	was	be	AUX
dpc-5848	22	35	maintained	maintain	VERB
dpc-5848	22	36	at	at	ADP
dpc-5848	22	37	7	7	NUM
dpc-5848	22	38	-	-	PUNCT
dpc-5848	22	39	month	month	NOUN
dpc-5848	22	40	follow	follow	NOUN
dpc-5848	22	41	up	up	ADP
dpc-5848	22	42	.	.	PUNCT
dpc-5848	23	1	no	no	DET
dpc-5848	23	2	obvious	obvious	ADJ
dpc-5848	23	3	side	side	NOUN
dpc-5848	23	4	effect	effect	NOUN
dpc-5848	23	5	was	be	AUX
dpc-5848	23	6	reported	report	VERB
dpc-5848	23	7	by	by	ADP
dpc-5848	23	8	the	the	DET
dpc-5848	23	9	patient	patient	NOUN
dpc-5848	23	10	.	.	PUNCT
dpc-5848	24	1	2	2	NUM
dpc-5848	24	2	research	research	NOUN
dpc-5848	24	3	letter	letter	NOUN
dpc-5848	24	4	|	|	ADV
dpc-5848	24	5	dermatol	dermatol	ADJ
dpc-5848	24	6	pract	pract	NOUN
dpc-5848	24	7	concept	concept	NOUN
dpc-5848	24	8	.	.	PUNCT
dpc-5848	25	1	2025;15(4):5848	2025;15(4):5848	NUM
dpc-5848	26	1	the	the	DET
dpc-5848	26	2	treatment	treatment	NOUN
dpc-5848	26	3	of	of	ADP
dpc-5848	26	4	erosive	erosive	ADJ
dpc-5848	26	5	olp	olp	PROPN
dpc-5848	26	6	includes	include	VERB
dpc-5848	26	7	systemic	systemic	ADJ
dpc-5848	26	8	corticosteroids	corticosteroid	NOUN
dpc-5848	26	9	,	,	PUNCT
dpc-5848	26	10	immunosuppressants	immunosuppressant	NOUN
dpc-5848	26	11	,	,	PUNCT
dpc-5848	26	12	and/or	and/or	CCONJ
dpc-5848	26	13	oral	oral	ADJ
dpc-5848	26	14	retinoids	retinoid	NOUN
dpc-5848	26	15	.	.	PUNCT
dpc-5848	27	1	[	[	X
dpc-5848	27	2	3	3	NUM
dpc-5848	27	3	]	]	SYM
dpc-5848	27	4	 	 	SPACE
dpc-5848	27	5	management	management	NOUN
dpc-5848	27	6	of	of	ADP
dpc-5848	27	7	erosive	erosive	ADJ
dpc-5848	27	8	olp	olp	PROPN
dpc-5848	27	9	has	have	AUX
dpc-5848	27	10	proven	prove	VERB
dpc-5848	27	11	to	to	PART
dpc-5848	27	12	be	be	AUX
dpc-5848	27	13	difficult;[4	difficult;[4	PROPN
dpc-5848	27	14	]	]	PUNCT
dpc-5848	27	15	however	however	ADV
dpc-5848	27	16	,	,	PUNCT
dpc-5848	27	17	 	 	SPACE
dpc-5848	27	18	jaki	jaki	PROPN
dpc-5848	27	19	 	 	SPACE
dpc-5848	27	20	such	such	ADJ
dpc-5848	27	21	as	as	ADP
dpc-5848	27	22	baricitinib	baricitinib	NOUN
dpc-5848	27	23	may	may	AUX
dpc-5848	27	24	represent	represent	VERB
dpc-5848	27	25	a	a	DET
dpc-5848	27	26	new	new	ADJ
dpc-5848	27	27	possible	possible	ADJ
dpc-5848	27	28	line	line	NOUN
dpc-5848	27	29	of	of	ADP
dpc-5848	27	30	treatment	treatment	NOUN
dpc-5848	27	31	.	.	PUNCT
dpc-5848	28	1	there	there	PRON
dpc-5848	28	2	are	be	VERB
dpc-5848	28	3	currently	currently	ADV
dpc-5848	28	4	16	16	NUM
dpc-5848	28	5	published	publish	VERB
dpc-5848	28	6	cases	case	NOUN
dpc-5848	28	7	of	of	ADP
dpc-5848	28	8	cutaneous	cutaneous	ADJ
dpc-5848	28	9	only	only	ADV
dpc-5848	28	10	lp	lp	ADV
dpc-5848	28	11	treated	treat	VERB
dpc-5848	28	12	with	with	ADP
dpc-5848	28	13	baricitinib	baricitinib	NOUN
dpc-5848	28	14	;	;	PUNCT
dpc-5848	28	15	nine	nine	NUM
dpc-5848	28	16	of	of	ADP
dpc-5848	28	17	them	they	PRON
dpc-5848	28	18	achieved	achieve	VERB
dpc-5848	28	19	complete	complete	ADJ
dpc-5848	28	20	or	or	CCONJ
dpc-5848	28	21	partial	partial	ADJ
dpc-5848	28	22	remission	remission	NOUN
dpc-5848	28	23	of	of	ADP
dpc-5848	28	24	the	the	DET
dpc-5848	28	25	disease	disease	NOUN
dpc-5848	28	26	,	,	PUNCT
dpc-5848	28	27	while	while	SCONJ
dpc-5848	28	28	in	in	ADP
dpc-5848	28	29	the	the	DET
dpc-5848	28	30	other	other	ADJ
dpc-5848	28	31	seven	seven	NUM
dpc-5848	28	32	,	,	PUNCT
dpc-5848	28	33	baricitinib	baricitinib	NOUN
dpc-5848	28	34	was	be	AUX
dpc-5848	28	35	not	not	PART
dpc-5848	28	36	able	able	ADJ
dpc-5848	28	37	to	to	PART
dpc-5848	28	38	improve	improve	VERB
dpc-5848	28	39	the	the	DET
dpc-5848	28	40	skin	skin	NOUN
dpc-5848	28	41	lesions.[2	lesions.[2	NOUN
dpc-5848	28	42	]	]	PUNCT
dpc-5848	29	1	moreover	moreover	ADV
dpc-5848	29	2	,	,	PUNCT
dpc-5848	29	3	a	a	DET
dpc-5848	29	4	case	case	NOUN
dpc-5848	29	5	report	report	NOUN
dpc-5848	29	6	of	of	ADP
dpc-5848	29	7	a	a	DET
dpc-5848	29	8	63	63	NUM
dpc-5848	29	9	-	-	PUNCT
dpc-5848	29	10	year	year	NOUN
dpc-5848	29	11	-	-	PUNCT
dpc-5848	29	12	old	old	ADJ
dpc-5848	29	13	female	female	ADJ
dpc-5848	29	14	presenting	presenting	NOUN
dpc-5848	29	15	with	with	ADP
dpc-5848	29	16	chronic	chronic	ADJ
dpc-5848	29	17	alopecia	alopecia	NOUN
dpc-5848	29	18	areata	areata	ADJ
dpc-5848	29	19	(	(	PUNCT
dpc-5848	29	20	aa	aa	NOUN
dpc-5848	29	21	)	)	PUNCT
dpc-5848	29	22	and	and	CCONJ
dpc-5848	29	23	coincidental	coincidental	ADJ
dpc-5848	29	24	acute	acute	ADJ
dpc-5848	29	25	olp	olp	PROPN
dpc-5848	29	26	was	be	AUX
dpc-5848	29	27	recently	recently	ADV
dpc-5848	29	28	published	publish	VERB
dpc-5848	29	29	.	.	PUNCT
dpc-5848	30	1	baricitinib	baricitinib	NOUN
dpc-5848	30	2	3.4	3.4	NUM
dpc-5848	30	3	 	 	SPACE
dpc-5848	30	4	mg	mg	PROPN
dpc-5848	30	5	twice	twice	ADV
dpc-5848	30	6	daily	daily	ADV
dpc-5848	30	7	was	be	AUX
dpc-5848	30	8	commenced	commence	VERB
dpc-5848	30	9	,	,	PUNCT
dpc-5848	30	10	with	with	ADP
dpc-5848	30	11	improvement	improvement	NOUN
dpc-5848	30	12	in	in	ADP
dpc-5848	30	13	olp	olp	PROPN
dpc-5848	30	14	after	after	ADP
dpc-5848	30	15	1	1	NUM
dpc-5848	30	16	 	 	SPACE
dpc-5848	30	17	month	month	NOUN
dpc-5848	30	18	and	and	CCONJ
dpc-5848	30	19	sustained	sustained	ADJ
dpc-5848	30	20	response	response	NOUN
dpc-5848	30	21	after	after	ADP
dpc-5848	30	22	four	four	NUM
dpc-5848	30	23	 	 	SPACE
dpc-5848	30	24	months	month	NOUN
dpc-5848	30	25	.	.	PUNCT
dpc-5848	31	1	except	except	SCONJ
dpc-5848	31	2	for	for	ADP
dpc-5848	31	3	mild	mild	ADJ
dpc-5848	31	4	hypercholesterolaemia	hypercholesterolaemia	NOUN
dpc-5848	31	5	,	,	PUNCT
dpc-5848	31	6	baricitinib	baricitinib	NOUN
dpc-5848	31	7	was	be	AUX
dpc-5848	31	8	well	well	ADV
dpc-5848	31	9	tolerated.[5	tolerated.[5	PRON
dpc-5848	31	10	]	]	PUNCT
dpc-5848	31	11	conclusion	conclusion	NOUN
dpc-5848	31	12	we	we	PRON
dpc-5848	31	13	report	report	VERB
dpc-5848	31	14	the	the	DET
dpc-5848	31	15	second	second	ADJ
dpc-5848	31	16	documented	document	VERB
dpc-5848	31	17	case	case	NOUN
dpc-5848	31	18	of	of	ADP
dpc-5848	31	19	erosive	erosive	ADJ
dpc-5848	31	20	olp	olp	PROPN
dpc-5848	31	21	that	that	PRON
dpc-5848	31	22	has	have	AUX
dpc-5848	31	23	been	be	AUX
dpc-5848	31	24	successfully	successfully	ADV
dpc-5848	31	25	treated	treat	VERB
dpc-5848	31	26	with	with	ADP
dpc-5848	31	27	baricitinib	baricitinib	NOUN
dpc-5848	31	28	,	,	PUNCT
dpc-5848	31	29	suggesting	suggest	VERB
dpc-5848	31	30	the	the	DET
dpc-5848	31	31	latter	latter	NOUN
dpc-5848	31	32	as	as	ADP
dpc-5848	31	33	a	a	DET
dpc-5848	31	34	potential	potential	ADJ
dpc-5848	31	35	new	new	ADJ
dpc-5848	31	36	therapeutic	therapeutic	ADJ
dpc-5848	31	37	option	option	NOUN
dpc-5848	31	38	in	in	ADP
dpc-5848	31	39	patients	patient	NOUN
dpc-5848	31	40	with	with	ADP
dpc-5848	31	41	recalcitrant	recalcitrant	ADJ
dpc-5848	31	42	erosive	erosive	NOUN
dpc-5848	31	43	olp	olp	PROPN
dpc-5848	31	44	.	.	PUNCT
dpc-5848	32	1	however	however	ADV
dpc-5848	32	2	,	,	PUNCT
dpc-5848	32	3	given	give	VERB
dpc-5848	32	4	the	the	DET
dpc-5848	32	5	conflicting	conflicting	ADJ
dpc-5848	32	6	results	result	NOUN
dpc-5848	32	7	reported	report	VERB
dpc-5848	32	8	in	in	ADP
dpc-5848	32	9	the	the	DET
dpc-5848	32	10	literature	literature	NOUN
dpc-5848	32	11	,	,	PUNCT
dpc-5848	32	12	further	far	ADV
dpc-5848	32	13	controlled	control	VERB
dpc-5848	32	14	studies	study	NOUN
dpc-5848	32	15	on	on	ADP
dpc-5848	32	16	larger	large	ADJ
dpc-5848	32	17	case	case	NOUN
dpc-5848	32	18	series	series	NOUN
dpc-5848	32	19	are	be	AUX
dpc-5848	32	20	needed	need	VERB
dpc-5848	32	21	to	to	PART
dpc-5848	32	22	evaluate	evaluate	VERB
dpc-5848	32	23	the	the	DET
dpc-5848	32	24	actual	actual	ADJ
dpc-5848	32	25	efficacy	efficacy	NOUN
dpc-5848	32	26	of	of	ADP
dpc-5848	32	27	baricitinib	baricitinib	NOUN
dpc-5848	32	28	in	in	ADP
dpc-5848	32	29	olp	olp	PROPN
dpc-5848	32	30	and	and	CCONJ
dpc-5848	32	31	lp	lp	ADJ
dpc-5848	32	32	patients	patient	NOUN
dpc-5848	32	33	.	.	PUNCT
dpc-5848	33	1	references	reference	NOUN
dpc-5848	33	2	1	1	NUM
dpc-5848	33	3	.	.	PUNCT
dpc-5848	33	4	gorouhi	gorouhi	PROPN
dpc-5848	33	5	f	f	PROPN
dpc-5848	33	6	,	,	PUNCT
dpc-5848	33	7	davari	davari	X
dpc-5848	34	1	p	p	X
dpc-5848	34	2	,	,	PUNCT
dpc-5848	34	3	fazel	fazel	ADJ
dpc-5848	34	4	n.	n.	NOUN
dpc-5848	34	5	cutaneous	cutaneous	ADJ
dpc-5848	34	6	and	and	CCONJ
dpc-5848	34	7	mucosal	mucosal	ADJ
dpc-5848	34	8	lichen	lichen	NOUN
dpc-5848	34	9	planus	planus	NOUN
dpc-5848	34	10	:	:	PUNCT
dpc-5848	34	11	a	a	DET
dpc-5848	34	12	comprehensive	comprehensive	ADJ
dpc-5848	34	13	review	review	NOUN
dpc-5848	34	14	of	of	ADP
dpc-5848	34	15	clinical	clinical	ADJ
dpc-5848	34	16	subtypes	subtype	NOUN
dpc-5848	34	17	,	,	PUNCT
dpc-5848	34	18	risk	risk	NOUN
dpc-5848	34	19	factors	factor	NOUN
dpc-5848	34	20	,	,	PUNCT
dpc-5848	34	21	diagnosis	diagnosis	NOUN
dpc-5848	34	22	,	,	PUNCT
dpc-5848	34	23	and	and	CCONJ
dpc-5848	34	24	prognosis	prognosis	NOUN
dpc-5848	34	25	.	.	PUNCT
dpc-5848	35	1	scientific	scientific	ADJ
dpc-5848	35	2	world	world	NOUN
dpc-5848	35	3	journal	journal	PROPN
dpc-5848	35	4	.	.	PUNCT
dpc-5848	36	1	2014	2014	NUM
dpc-5848	36	2	jan	jan	PROPN
dpc-5848	36	3	30;2014:742826	30;2014:742826	PROPN
dpc-5848	36	4	.	.	PUNCT
dpc-5848	37	1	doi	doi	NOUN
dpc-5848	37	2	:	:	PUNCT
dpc-5848	37	3	10.1155/2014/742826	10.1155/2014/742826	NUM
dpc-5848	37	4	.	.	PUNCT
dpc-5848	38	1	pmid	pmid	NOUN
dpc-5848	38	2	:	:	PUNCT
dpc-5848	38	3	24672362	24672362	NUM
dpc-5848	38	4	;	;	PUNCT
dpc-5848	38	5	pmcid	pmcid	NOUN
dpc-5848	38	6	:	:	PUNCT
dpc-5848	38	7	pmc3929580	pmc3929580	NOUN
dpc-5848	38	8	.	.	PUNCT
dpc-5848	39	1	2	2	X
dpc-5848	39	2	.	.	X
dpc-5848	39	3	abduelmula	abduelmula	PROPN
dpc-5848	39	4	a	a	PRON
dpc-5848	39	5	,	,	PUNCT
dpc-5848	39	6	bagit	bagit	ADV
dpc-5848	39	7	a	a	X
dpc-5848	39	8	,	,	PUNCT
dpc-5848	39	9	mufti	mufti	PROPN
dpc-5848	39	10	a	a	PROPN
dpc-5848	39	11	,	,	PUNCT
dpc-5848	39	12	yeung	yeung	PROPN
dpc-5848	39	13	kcy	kcy	PROPN
dpc-5848	39	14	,	,	PUNCT
dpc-5848	40	1	yeung	yeung	PROPN
dpc-5848	40	2	j.	j.	PROPN
dpc-5848	41	1	the	the	DET
dpc-5848	41	2	use	use	NOUN
dpc-5848	41	3	of	of	ADP
dpc-5848	41	4	janus	janus	PROPN
dpc-5848	41	5	kinase	kinase	PROPN
dpc-5848	41	6	inhibitors	inhibitor	NOUN
dpc-5848	41	7	for	for	ADP
dpc-5848	41	8	lichen	lichen	NOUN
dpc-5848	41	9	planus	planus	NOUN
dpc-5848	41	10	:	:	PUNCT
dpc-5848	41	11	an	an	DET
dpc-5848	41	12	evidence	evidence	NOUN
dpc-5848	41	13	-	-	PUNCT
dpc-5848	41	14	based	base	VERB
dpc-5848	41	15	review	review	NOUN
dpc-5848	41	16	.	.	PUNCT
dpc-5848	42	1	j	j	PROPN
dpc-5848	42	2	cutan	cutan	PROPN
dpc-5848	42	3	med	med	ADJ
dpc-5848	42	4	surg	surg	NOUN
dpc-5848	42	5	.	.	PUNCT
dpc-5848	43	1	2023	2023	NUM
dpc-5848	43	2	may	may	AUX
dpc-5848	43	3	-	-	PUNCT
dpc-5848	43	4	jun;27(3):271	jun;27(3):271	NOUN
dpc-5848	43	5	-	-	PUNCT
dpc-5848	43	6	276	276	NUM
dpc-5848	43	7	.	.	PUNCT
dpc-5848	44	1	doi	doi	NOUN
dpc-5848	44	2	:	:	PUNCT
dpc-5848	44	3	10.1177/12034754231156100	10.1177/12034754231156100	NUM
dpc-5848	44	4	.	.	X
dpc-5848	44	5	epub	epub	PROPN
dpc-5848	44	6	2023	2023	NUM
dpc-5848	44	7	feb	feb	NOUN
dpc-5848	44	8	23	23	NUM
dpc-5848	44	9	.	.	PUNCT
dpc-5848	45	1	pmid	pmid	NOUN
dpc-5848	45	2	:	:	PUNCT
dpc-5848	45	3	36815857	36815857	NUM
dpc-5848	45	4	;	;	PUNCT
dpc-5848	45	5	pmcid	pmcid	ADJ
dpc-5848	45	6	:	:	PUNCT
dpc-5848	45	7	pmc10291104	pmc10291104	NOUN
dpc-5848	45	8	.	.	PUNCT
dpc-5848	46	1	3	3	X
dpc-5848	46	2	.	.	X
dpc-5848	46	3	thandar	thandar	PROPN
dpc-5848	46	4	y	y	PROPN
dpc-5848	46	5	,	,	PUNCT
dpc-5848	46	6	maharajh	maharajh	PROPN
dpc-5848	46	7	r	r	NOUN
dpc-5848	46	8	,	,	PUNCT
dpc-5848	46	9	haffejee	haffejee	NOUN
dpc-5848	46	10	f	f	NOUN
dpc-5848	46	11	,	,	PUNCT
dpc-5848	46	12	mosam	mosam	NOUN
dpc-5848	46	13	a.	a.	NOUN
dpc-5848	46	14	treatment	treatment	NOUN
dpc-5848	46	15	of	of	ADP
dpc-5848	46	16	cutaneous	cutaneous	ADJ
dpc-5848	46	17	lichen	lichen	NOUN
dpc-5848	46	18	planus	planus	NOUN
dpc-5848	46	19	(	(	PUNCT
dpc-5848	46	20	part	part	NOUN
dpc-5848	46	21	2	2	NUM
dpc-5848	46	22	):	):	PUNCT
dpc-5848	46	23	a	a	DET
dpc-5848	46	24	review	review	NOUN
dpc-5848	46	25	of	of	ADP
dpc-5848	46	26	systemic	systemic	ADJ
dpc-5848	46	27	therapies	therapy	NOUN
dpc-5848	46	28	.	.	PUNCT
dpc-5848	47	1	j	j	PROPN
dpc-5848	47	2	dermatolog	dermatolog	PROPN
dpc-5848	47	3	treat	treat	NOUN
dpc-5848	47	4	.	.	PUNCT
dpc-5848	48	1	2019	2019	NUM
dpc-5848	48	2	nov;30(7):633	nov;30(7):633	NOUN
dpc-5848	48	3	-	-	SYM
dpc-5848	48	4	647	647	NUM
dpc-5848	48	5	.	.	PUNCT
dpc-5848	49	1	doi	doi	NOUN
dpc-5848	49	2	:	:	PUNCT
dpc-5848	49	3	10.1080/09546634.2018.1544411	10.1080/09546634.2018.1544411	NUM
dpc-5848	49	4	.	.	PUNCT
dpc-5848	50	1	epub	epub	PROPN
dpc-5848	50	2	2018	2018	NUM
dpc-5848	50	3	dec	dec	PROPN
dpc-5848	50	4	11	11	NUM
dpc-5848	50	5	.	.	PUNCT
dpc-5848	51	1	pmid	pmid	NOUN
dpc-5848	51	2	:	:	PUNCT
dpc-5848	51	3	30451042	30451042	NUM
dpc-5848	51	4	.	.	PUNCT
dpc-5848	52	1	4	4	X
dpc-5848	52	2	.	.	X
dpc-5848	52	3	balestri	balestri	PROPN
dpc-5848	52	4	r	r	PROPN
dpc-5848	52	5	,	,	PUNCT
dpc-5848	52	6	bortolotti	bortolotti	NOUN
dpc-5848	52	7	r	r	NOUN
dpc-5848	52	8	,	,	PUNCT
dpc-5848	52	9	rech	rech	VERB
dpc-5848	52	10	g	g	NOUN
dpc-5848	52	11	,	,	PUNCT
dpc-5848	52	12	girardelli	girardelli	PROPN
dpc-5848	52	13	cr	cr	PROPN
dpc-5848	52	14	,	,	PUNCT
dpc-5848	52	15	zorzi	zorzi	VERB
dpc-5848	52	16	mg	mg	PROPN
dpc-5848	52	17	,	,	PUNCT
dpc-5848	52	18	magnano	magnano	PROPN
dpc-5848	52	19	m.	m.	NOUN
dpc-5848	52	20	treatment	treatment	NOUN
dpc-5848	52	21	of	of	ADP
dpc-5848	52	22	oral	oral	ADJ
dpc-5848	52	23	erosive	erosive	ADJ
dpc-5848	52	24	lichen	lichen	NOUN
dpc-5848	52	25	planus	planus	NOUN
dpc-5848	52	26	with	with	ADP
dpc-5848	52	27	upadacitinib	upadacitinib	NOUN
dpc-5848	52	28	.	.	PUNCT
dpc-5848	52	29	  	  	SPACE
dpc-5848	53	1	jama	jama	NOUN
dpc-5848	53	2	dermatol	dermatol	NOUN
dpc-5848	53	3	.	.	PUNCT
dpc-5848	54	1	2022	2022	NUM
dpc-5848	54	2	apr	apr	NOUN
dpc-5848	54	3	1;158(4):457	1;158(4):457	NUM
dpc-5848	54	4	-	-	SYM
dpc-5848	54	5	458	458	NUM
dpc-5848	54	6	.	.	PUNCT
dpc-5848	55	1	doi	doi	NOUN
dpc-5848	55	2	:	:	PUNCT
dpc-5848	55	3	10.1001	10.1001	NUM
dpc-5848	55	4	/	/	SYM
dpc-5848	55	5	jamadermatol.2022.0147	jamadermatol.2022.0147	PROPN
dpc-5848	55	6	.	.	PUNCT
dpc-5848	55	7	 	 	SPACE
dpc-5848	56	1	pmid	pmid	NOUN
dpc-5848	56	2	:	:	PUNCT
dpc-5848	56	3	35294521	35294521	NUM
dpc-5848	56	4	.	.	PUNCT
dpc-5848	57	1	5	5	X
dpc-5848	57	2	.	.	X
dpc-5848	57	3	moussa	moussa	PROPN
dpc-5848	57	4	a	a	PROPN
dpc-5848	57	5	,	,	PUNCT
dpc-5848	57	6	colla	colla	PROPN
dpc-5848	57	7	t	t	PROPN
dpc-5848	57	8	,	,	PUNCT
dpc-5848	57	9	morrison	morrison	PROPN
dpc-5848	57	10	b	b	PROPN
dpc-5848	57	11	,	,	PUNCT
dpc-5848	57	12	sinclair	sinclair	PROPN
dpc-5848	57	13	r.	r.	PROPN
dpc-5848	57	14	effective	effective	ADJ
dpc-5848	57	15	treatment	treatment	NOUN
dpc-5848	57	16	of	of	ADP
dpc-5848	57	17	oral	oral	ADJ
dpc-5848	57	18	lichen	lichen	NOUN
dpc-5848	57	19	planus	planus	NOUN
dpc-5848	57	20	with	with	ADP
dpc-5848	57	21	the	the	DET
dpc-5848	57	22	jak	jak	PROPN
dpc-5848	57	23	inhibitor	inhibitor	NOUN
dpc-5848	57	24	baricitinib	baricitinib	NOUN
dpc-5848	57	25	.	.	PUNCT
dpc-5848	58	1	australas	australas	PROPN
dpc-5848	58	2	j	j	PROPN
dpc-5848	58	3	dermatol	dermatol	NOUN
dpc-5848	58	4	.	.	PUNCT
dpc-5848	59	1	2022	2022	NUM
dpc-5848	59	2	may;63(2):276	may;63(2):276	NOUN
dpc-5848	59	3	-	-	PUNCT
dpc-5848	59	4	277	277	NUM
dpc-5848	59	5	.	.	PUNCT
dpc-5848	60	1	doi	doi	NOUN
dpc-5848	60	2	:	:	PUNCT
dpc-5848	60	3	10.1111	10.1111	NUM
dpc-5848	60	4	/	/	SYM
dpc-5848	60	5	ajd.13811	ajd.13811	PROPN
dpc-5848	60	6	.	.	PUNCT
dpc-5848	61	1	epub	epub	PROPN
dpc-5848	61	2	2022	2022	NUM
dpc-5848	61	3	feb	feb	NOUN
dpc-5848	61	4	25	25	NUM
dpc-5848	61	5	.	.	PUNCT
dpc-5848	62	1	pmid	pmid	NOUN
dpc-5848	62	2	:	:	PUNCT
dpc-5848	62	3	35213737	35213737	NUM
dpc-5848	62	4	.	.	PUNCT
dpc-5848	63	1	figure	figure	NOUN
dpc-5848	63	2	1	1	NUM
dpc-5848	63	3	.	.	PUNCT
dpc-5848	64	1	painful	painful	ADJ
dpc-5848	64	2	erosions	erosion	NOUN
dpc-5848	64	3	and	and	CCONJ
dpc-5848	64	4	ulcerations	ulceration	NOUN
dpc-5848	64	5	of	of	ADP
dpc-5848	64	6	the	the	DET
dpc-5848	64	7	tongue	tongue	NOUN
dpc-5848	64	8	(	(	PUNCT
dpc-5848	64	9	a	a	NOUN
dpc-5848	64	10	)	)	PUNCT
dpc-5848	64	11	complete	complete	ADJ
dpc-5848	64	12	remission	remission	NOUN
dpc-5848	64	13	of	of	ADP
dpc-5848	64	14	the	the	DET
dpc-5848	64	15	oral	oral	ADJ
dpc-5848	64	16	disease	disease	NOUN
dpc-5848	64	17	after	after	ADP
dpc-5848	64	18	five	five	NUM
dpc-5848	64	19	months	month	NOUN
dpc-5848	64	20	of	of	ADP
dpc-5848	64	21	baricitinib	baricitinib	NOUN
dpc-5848	64	22	(	(	PUNCT
dpc-5848	64	23	b	b	NOUN
dpc-5848	64	24	)	)	PUNCT
dpc-5848	64	25	.	.	PUNCT